Show simple item record

dc.contributor.authorOguro-Ando, A
dc.contributor.authorZuko, A
dc.contributor.authorKleijer, KTE
dc.contributor.authorBurbach, JPH
dc.date.accessioned2018-05-02T10:31:38Z
dc.date.issued2017-01-05
dc.description.abstractContactins (Cntns) are a six-member subgroup of the immunoglobulin cell adhesion molecule superfamily (IgCAMs) with pronounced brain expression and function. Recent genetic studies of neuropsychiatric disorders have pinpointed contactin-4 (CNTN4), contactin-5 (CNTN5) and contactin-6 (CNTN6) as candidate genes in neurodevelopmental disorders, particularly in autism spectrum disorders (ASDs), but also in intellectual disability, schizophrenia (SCZ), attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BD), alcohol use disorder (AUD) and anorexia nervosa (AN). This suggests that they have important functions during neurodevelopment. This suggestion is supported by data showing that neurite outgrowth, cell survival and neural circuit formation can be affected by disruption of these genes. Here, we review the current genetic data about their involvement in neuropsychiatric disorders and explore studies on how null mutations affect mouse behavior. Finally, we highlight to role of protein-protein interactions in the potential mechanism of action of Cntn4, -5 and -6 and emphasize that complexes with other membrane proteins may play a role in neuronal developmental functions.en_GB
dc.description.sponsorshipAuthors of this review were supported by EU-AIMS (European Autism Interventions), which receives support from the Innovative Medicines Initiative Joint Undertaking under Grant agreement no.115300, there sources of which are composed of financial contributions from the European Union's Seventh Framework Programed Grant (P7/2007–2013), from the European Federation of Pharmaceutical Industries and Associations Companies' in-kind contributions, and from Autism Speaks. (K.T.E.K. and J.P.H.B.), by a Fellowship from JSPS (A.O.A. and A.Z).en_GB
dc.identifier.citationVol. 81, pp. 72 - 83en_GB
dc.identifier.doi10.1016/j.mcn.2016.12.004
dc.identifier.urihttp://hdl.handle.net/10871/32685
dc.language.isoenen_GB
dc.publisherElsevieren_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/28064060en_GB
dc.rights© 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/en_GB
dc.subjectADHDen_GB
dc.subjectAlcohol use disorderen_GB
dc.subjectAnorexia nervosaen_GB
dc.subjectAutismen_GB
dc.subjectBipolar disorderen_GB
dc.subjectCell adhesion moleculesen_GB
dc.subjectContactinen_GB
dc.subjectIgCAMsen_GB
dc.subjectNeurodevelopmental disorderen_GB
dc.subjectNeuropsychiatric disorderen_GB
dc.subjectSchizophreniaen_GB
dc.subjectAnimalsen_GB
dc.subjectContactinsen_GB
dc.subjectHumansen_GB
dc.subjectLoss of Function Mutationen_GB
dc.subjectNeurodevelopmental Disordersen_GB
dc.titleA current view on contactin-4, -5, and -6: Implications in neurodevelopmental disorders.en_GB
dc.typeArticleen_GB
dc.date.available2018-05-02T10:31:38Z
dc.identifier.issn1044-7431
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record.en_GB
dc.identifier.journalMolecular and Cellular Neuroscienceen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record